The pathogenesis of pulmonary infection and the immune response following intranasal inoculation of mice with two equine herpesvirus type 1 (EHV-1) deletion mutants have been assessed. The mutants, ED71 and ED75, have deletions in genes 71 (EUS4) and 75 (10K), respectively. Deletions were replaced by the Escherichia coli lacZ gene driven by the simian virus 40 (SV40) early promoter. It has previously been shown that the protein products of genes 71 and 75 are dispensable in vitro but that removal of gene 71 results in a defect in virus maturation and capsid envelopment which impairs the ability of mutant virus to spread via release and readsorption. This study demonstrated that the 192-kDa gene 71 product is required for full expression of virulence in mice, whereas the putative 10-kDa product of gene 75 has minimal effect. Both mutants exhibited the same tissue and cytotropism as wild-type EHV-1 and induced both humoral and cell-mediated immune responses indistinguishable from those induced by the parental strain. Irrespective of the reduced pathogenicity of the gene 71 mutant, infected mice were protected against a challenge with wild-type EHV-1. These findings highlight the potential of ED71 as a vaccine candidate.
INTRODUCTION
1995); and genes 1, 2, 67, 71, and 75 in EHV-1 (Audonnet et al., 1992; Breeden et al., 1992; Colle et al., 1992 ; Telford Equine herpesvirus type 1 (EHV-1) is a prevalent et al. , 1992) . Counterparts of EHV-1 genes 71 (also desigequine pathogen which belongs to the subfamily Alphanated EUS4) and 75 (also designated 10K) are also herpesvirinae (Roizman, 1992) . Infection results espethought to exist in EHV-4 (Cullinane et al., 1988 ; Nagesha cially in respiratory disease, although abortion and neu et al., 1993) . Of the five unique EHV-1 genes three, genes rological disease may also present 67 , and 75, were initially thought to have neither posidert, 1983; Allen and Bryans, 1986; Bryans and Allen, tional nor sequence counterparts in other herpesviruses 1989). The genome sequence and gene arrangement of (Telford et al., 1992) . However, positional counterparts of a neuropathogenic isolate, Ab4, herein designated genes 1 and 75 have since been found in other AlphaherwtAb4p, have been determined by Telford et al. (1992) .
pesvirinae. EHV-1 gene 1 has a counterpart in pseudoraThe genome comprises two unique components, U L bies virus (PRV) (Baumeister et al., 1995) , and positional (112870 bp) and U S (11861 bp), each bounded by inverted homologs of EHV-1 gene 75 have been identified in HSVrepeat sequences TR L /IR L (32 bp) and IR S /TR S (12714 bp), 1 (Georgopoulou et al., 1993) , and feline herpesvirus type respectively. The short genome component exhibits the 1 (FHV-1) (Willemse et al., 1995) . No definite functions greatest degree of sequence diversity among the Alphahave yet been assigned to any of the unique genes deherpesvirinae described to date (Davison and Wilkie, scribed above; however, their virus species-specificity 1983), with a number of unique open reading frames suggests that they might encode factors which confer a (ORFs) having been identified only in particular members growth advantage in their respective natural hosts by of the subfamily. Exclusive short genome component perhaps potentiating spread to a specific organ or cell ORFs found among the Alphaherpesvirinae include: U S 5, type within that host. Alternatively, they might serve in the U S 11, and U S 12 in herpes simplex virus type 1 (HSV-1) disabling of a particular specific or nonspecific antiviral (McGeoch et al., 1985) and herpes simplex virus type 2 response in the host. Thus an understanding of the func-(HSV-2) (McGeoch et al., 1987) ; U S 8.5 in HSV-1 (Georgotions of these unique genes is likely to be important if poulou et al., 1993) ; ORF 1 in bovine herpesvirus type 1 we are to further our knowledge of the molecular mecha-(BHV-1) (Leung-Tack et al., 1994) ; sORF 1, 2, 3, and 4 in nisms underlying herpesvirus pathogenesis. Marek's disease virus (MDV) (Brunovskis and Velicer,
We present a phenotypic analysis in a well-defined murine model for EHV-1 infection (Awan et al., 1990 (Awan et al., , et al., 1994 Osterrieder et al., 1995) of two isogenic bgalactosidase-positive (b-gal / ) deletion mutants of EHV-1, designated ED71 and ED75, with the Escherichia coli lacZ gene under control of the simian virus 40 (SV40) early enhancer/promoter replacing deletions in genes 71 and 75, respectively. Using these mutants it has been shown previously that neither gene 71 nor gene 75 is required for EHV-1 replication in tissue culture . However, the gene 71 product has been recently shown to play a part in virus adsorption, penetration, and egress from tissue culture cells (Sun et al., 1996) . The mutants, ED71 and ED75, form part of a series of EHV-1 lacZ recombinants which have been constructed to facilitate the study of the functions of a number of genes unique to EHV-1 Sun et al., 1995) . This paper represents the first account of the in vivo properties of two of these mutants.
MATERIALS AND METHODS

Cells and viruses
All viruses used were derived from EHV-1 strain Ab4. Two wild-type viruses, termed wtAb4 and wtAb4p, were respectively. ORFs are numbered according to the nomenclature of Telford et al. (1992) in rabbit kidney fibroblast (RK-13) cells (Christofinis and Beale, 1968) grown at 37Њ in Eagle's minimal essential medium (EMEM) containing 1% fetal calf serum (FCS).
signs. Sixteen mice from each of the experimental groups The construction of mutants ED71 and ED75 has been were used for virus isolation, with 4 mice being killed described in detail by . ED71 has from each group on Days 1, 3, 5, and 7 postinfection a 1811-bp deletion in gene 71 replaced by a cassette (p.i.). A further 4 mice were used for the collection of containing the lacZ gene under the control of the SV40 serum samples from the tail vein on Days 0, 3, 7, 14, early enhancer/promoter (Fig. 1b) . ED75 contains the 21, 28, 42, and 56 p.i. for enzyme-linked immunosorbent same cassette replacing a 189 bp deletion in gene 75 assay (ELISA). After collection of the final serum samples, (Fig. 1b) . Thus 76 and 48%, respectively, of the coding the same animals were used for determination of cellsequences of genes 71 and 75 have been deleted. The mediated immune responses by delayed-type hypersencorrect points of insertion of the lacZ cassette in ED71 sitivity (DTH) skin tests. The remaining 8 mice from each and ED75 have been previously confirmed by restriction group were used for histology, X-gal reaction, and elecenzyme digestion . tron microscopy. All experiments included negative controls comprising uninfected mice as well as mice having Experimental procedures received RK-13 cell lysates. Challenge experiments were performed on three groups of 20 mice immunized by i.n. All in vivo experiments were performed using female 4-week-old BALB/c mice obtained from Bantin and Kinginoculation with 1 1 10 7 PFU/mouse of wtAb4p, ED71, or ED75. Control mice were immunized with RK-13 cell man (Grimston, Aldbrough, Hull, UK). Infections were established as described previously (Awan et al., 1990) by lysate. Inoculum titers were reconfirmed as above and, on Days 3 and 5 p.i., virus isolations were made from 2 i.n. infection with 1 1 10 7 PFU/mouse of the parental virus wtAb4p, ED71, or ED75. Inoculum titers were reconmice in each group to verify that infections had been established successfully (not shown). After 60 days, all firmed by back titration of residual inoculum. In order to study primary infections in the mouse, three groups of surviving mice were given an i.n. challenge with 1 1 10 8 PFU (LD 50 1 20) of wtAb4. Serum antibody titers were 34 mice were infected i.n. with virus. Six mice from each group were caged separately and used to record clinical measured in 4 mice on Days 04, 0, 3, 7, 14, 21, and 28 postchallenge infection (p.c.i.) by indirect ELISA. On Day 28 p.c.i. DTH skin tests were performed in the same 4 mice from each group. Virus clearance rates from nasal turbinates and lung were determined by plaque-assay of tissue homogenates prepared from 3 mice on Days 1, 3, and 5 p.c.i. Three additional groups of 10 mice which had been immunized with wtAb4p, ED75, or ED71 and subsequently challenged as above were housed separately and used to record clinical signs. The extent to which mutant viruses were attenuated was evaluated by intracerebral (i.c.) injection. Increasing doses of virus suspended in 20 ml of EMEM were injected at a depth of approximately 2 mm into the left cerebral hemisphere of groups of six 4-week-old anesthetized BALB/c mice. Survival rates were then recorded over a 14-day period.
Rescue of ED71 and ED75
Two rescuants of ED71 and ED75, termed RED71 and RED75, respectively, were constructed. The 10.5-kb BamHI ''D'' fragment of EHV-1 containing most of the Data points represent mean percentages { SD; n Å 6. unique short genome component was cloned into pBR322 to give plasmid pBRD. Following double digestion of pBRD with BamHI and EcoRI, the 5.8-kb D1 and RESULTS 4.7-kb D2 subfragments (Fig. 1b) were purified from electrophoresis gels by the glass powder method (Qiagen, Pathogenesis following i.n. infection in BALB/c mice UK). The D1 and D2 fragments were then cotransfected
The severity of clinical signs following i.n. infection at along with ED71 and ED75 DNA into RK-13 cells, respec-1 1 10 7 PFU/mouse occurred in the order: wtAb4p ú tively, using the method of Stow et al. (1976) . Rescued ED75 ú ED71. On Day 1 p.i. all mice were hunched and viruses were selected by blue/white screening in the had ruffled fur. At 3 days p.i. wtAb4p-and ED75-infected presence of 0.05 mg/ml X-gal (5-bromo-4-chloro-3-indoyl mice continued to show these signs and their breathing b-D-galactopyranoside) and were subsequently plaquewas labored (dyspnoea) and abdominal as well as more purified three times. rapid (tachypnoea) than that of control mice. Substantial weight loss was also evident in these groups, while X-gal reaction ED71-infected mice showed no obvious clinical signs and weights had started to return toward preinfection Whole tissues to be reacted with X-gal were fixed in values (Fig. 2) . At 5 days p.i., wtAb4p-and ED75-infected 4% paraformaldehyde on ice for 1 hr. After being washed mice showed average weight losses of around 47 and in PBS, the tissues were placed in X-gal reaction solution 21% of preinfection values, respectively, whereas ED71-(0.1% (w/v) Na desoxycholate, 0.1% (v/v) NP-40, 5 mM infected mice had attained their preinfection weights at potassium ferricyanide, 5 mM potassium ferrocyanide, 2 this time (Fig. 2) . wtAb4p-infected mice remained abnormM MgCl 2 , and 1 mg/ml X-gal) and incubated for 18 hr mal for up to 12 days p.i., and two deaths occurred at 8 at 33Њ. After being washed in PBS, they were fixed in 10% days p.i. Both fatalities occurred in animals whose Formalin overnight prior to embedding and sectioning.
weights had dropped below 7 g. No deaths were reSections were counterstained with hematoxylin and eocorded in either the ED75-or ED71-infected groups. sin and mounted with DPX (BDH, Poole, UK).
The ability of mutants ED71 and ED75 to replicate in the respiratory tissues of the BALB/c mouse was compared by assay for infectious virus in nasal turbinate and Other methods lung homogenates. Replication of mutant ED75 in the nasal turbinates mirrored that of the parent virus, and Methods for the titration of viruses in tissue samples, preparation of tissues for histological and electron microno significant differences were observed between the groups at the time points examined (Fig. 3a) . The lung scopic examination, ELISA, and DTH skin tests were as described previously (Awan et al., 1990; Azmi and Field, virus content was also similar in the ED75-and wtAb4p-infected groups; however, a significant reduction in virus 1993a). EHV-1 GENE 71 DELETION MUTANT titer was recorded (Fig. 3b ) at 7 days p.i. in ED75-infected In agreement with the cytotropism of wtAb4 in lung, as previously determined by immunohistochemical staining animals (Student's t test P õ 0.05). In contrast, ED71 replicated poorly in respiratory tissues, as evidenced by and in situ hybridization (Awan et al., 1990; Baxi et al., 1996) , the bronchial and bronchiolar epithelia were found rapid virus clearance from both nasal turbinates and lung (Figs. 3a and 3b) , while the ED71 rescuant, RED71, replito be infected with ED75 and ED71, as evidenced by deposits of blue reaction product within the ciliated epicated with wild-type kinetics in both nasal turbinates and lung (not shown).
thelium following reaction of whole lung with the chromo -FIG. 4 . Sections through the lung of 4-week-old female BALB/c mice infected with 1 1 10 7 PFU of ED75 (A) or ED71 (B). The sections were counterstained with H / E following whole tissue X-gal reaction at 5 and 2 days p.i., respectively. In both (A) and (B) the bronchiole B is lined with blue b-gal / epithelial cells (arrow) indicating the presence of b-gal / ED75 and ED71, respectively. Epithelial cells are seen detaching and desquamating into the lumen (L). mediated immune responses induced against wtAb4 in the wtAb4p-, ED75-, or ED71-immunized groups ( Fig. 5b and Table 3 ). genic substrate X-gal (Figs. 4A and 4B) . No evidence of b-galactosidase activity was found in the lungs of mice infected with either the lacZ-negative parent virus or RK-DISCUSSION 13 cell lysate. In general, lung pathology following ED71
The salient points of our research were (i) deletion of infection was milder than that observed in wtAb4p-or the gene 71 ORF (EUS4) resulted in a virus exhibiting a ED75-infected mice. Consolidation of the pulmonary tisgreatly attenuated phenotype following i.n. infection in sue, a prominent feature of the lung pathology observed BALB/c mice and in agreement with the in vitro findings in wtAb4p-and ED75-infected animals, was not observed of Sun et al. (1996) there was an obvious deficit of envein ED71-infected mice.
loped virions in infected epithelial cells, with little or no In order to reaffirm the apparent attenuated phenoreduplication and invagination of the nuclear membrane; types of ED71 and ED75, the survival rates in mice were
(ii) deletion of gene 71 had no apparent effect upon stimucompared following i.c. infection with increasing titers of lation of antibody or cell-mediated immune responses; wild-type and mutant viruses. Groups of six mice were (iii) a gene 75 deletion mutant was moderately attenuated infected with 1 1 10 5 , 5 1 10 5 , 1 1 10 6 , 1 1 10 7 , or 1 in this infection model; (iv) the wild-type phenotype could 1 10 8 PFU/mouse and monitored over a 14-day period. be restored by constructing rescuant viruses; and (v) both Numbers of mice surviving after 14 days are given in ED71 and ED75 conferred protection against lethal dose Table 1 . Survival rates of 100% were recorded for all wild-type challenge. groups when inoculated at a titer of 1 1 10 5 PFU/mouse. The gene 71 product is thought to be a high-abunAt 5 1 10 5 PFU this decreased to 50% in mice infected dance highly glycosylated membrane glycoprotein (Sun with wild-type virus and decreased further to 33% at 1 1 et al., 1994) , and it is perhaps not unexpected that its 10 6 PFU. At a dose greater than or equal to 1 1 10 7 PFU absence from the ED71 envelope culminates in having no mice survived a wild-type infection. In the case of such a marked effect upon EHV-1 pathogenicity. A promi-ED75, a dose of 1 1 10 6 PFU was needed to cause nent feature of the gene 71 protein is a region of relethality, with a survival rate of 67%. At 1 1 10 7 PFU this peating serine and threonine residues believed to be decreased to 33%. All mice inoculated with the mutant sites of O-linked glycosylation. This glycosylated protein ED71 survived the infection, including those receiving domain has been proposed to form a semiflexible rod of the maximum dose of 1 1 10 8 PFU. some 70 nm in length situated on the outer surface of the virion envelope (McGeoch et al., 1993) . The absence Immune responses to wtAb4p, ED75, and ED71
of such a topographic feature on the virion envelope surface might well be expected to have a deleterious Examination of the primary antibody (IgG and IgM) and cell-mediated immune responses elicited in mice effect upon virus replication. The nonappearance of gene 71 in other Alphaherpesvirinae but its requirement for infected with either of the recombinant viruses or the parental strain revealed no detectable differences in the efficient virus adsorption, penetration, egress (Sun et al., 1996) , and full expression of EHV-1 virulence in vivo magnitude and duration of antibody or cell-mediated immune responses (Fig. 5a and Table 2 ). Following i.n.
would suggest that the biological functions provided by the gene 71 product are supplied by other membrane challenge infection with wtAb4, wtAb4p-and ED75-immunized mice showed only moderate weight losses p.c.i.
glycoproteins in other Alphaherpesvirinae. HSV-1 U S 5, the positional homolog of gene 71, has of around 5% of preinfection weights, and survival rates in a group size of 10 mice were 100% in both cases. No been demonstrated to be nonessential both in vitro and in the mouse (Balan et al., 1994) . However, the U S 5 proclinical signs of infection were evident in either group. ED71-protected mice showed mild signs of EHV-1 infectein displays no homology to the gene 71 product (Fast A score 24) (Telford et al., 1992) and encodes a much Colle et al. (1996) have recently determined that the Kentucky A (KyA) strain of EHV-1 lacking ORFs 1 and 2 smaller 92-amino-acid protein (McGeoch et al., 1985) .
Much of the region deleted in gene 71 in the mutant and those encoding EHV-1 homologs of gI, gE, and a potential 10-kDa protein (gene 75), as well as having ED71 comprises a series of tandem sequence reiterations. As suggested previously by Telford et al. (1992) , substantial deletions in ORF 17 and EUS4 (gene 71), is greatly attenuated in the mouse model. Moreover, KyA indirect evidence that these tandem reiterations are important determinants of protein structure and function has also been shown to be attenuated in the horse (Matsumura et al., 1996) . It is not known which of the deletions comes from the fact that both EHV-1 gene 24 and its HSV-1 counterpart, UL36, contain tandem repeat elements in in KyA are directly responsible for the decrease in virulence; however, from our own observations it is clear that the same location of their coding sequences. Possibly, expansion or contraction of the region comprising the the deletion in gene 71 (EUS4) is a contributory factor. Deletion of gene 75 (10K) had little effect upon virus tandem reiterations of gene 71 has an effect upon protein folding and protein topography. In turn, this might influreplication and pathogenicity in mice. Although we did observe a significant reduction in weight loss in mice ence the affinity of the gene 71 product for a putative cellular receptor affecting virus infectivity and hence the infected with ED75 (Fig. 2) compared to mice receiving wild-type infections, this did not reflect the degree of pathogenicity of the virus.
lung pathology or the extent of virus replication observed in ED75-infected mice, which suggested only a moder- noting that, in the case of HSV-1, the considerable overof mice with EHV-4, which does not replicate in the mouse, has been shown previously to confer protection lap between U S 8 (gE) and U S 8.5 coding sequences means that many gE 0 mutants will also be U S 8.5 0 , a fact against subsequent EHV-1 challenge (Azmi and Field, 1993b) . However, in this instance mice became sensinot recognized before U S 8.5 was identified by Georgopoulou et al. (1993) .
tized, resulting in an increase in immunopathology, particularly in the lung (Azmi and Field, 1993b) . These results There were no observable differences in magnitude and duration of primary and secondary humoral or cellsuggest that ED71 might merit further evaluation in the natural host as a potential EHV-1 vaccine. mediated immune responses in mice infected with either parental or recombinant viruses. The antibody responses to all three viruses were very low; however, this has been ACKNOWLEDGMENTS observed previously (Awan et al., 1990; Azmi and Field, We thank the Equine Virology Research Foundation for generous unpublished observations). Both ED75 and ED71 prosupport. K.R.M. gratefully acknowledges funding from the Biotechnoltected against wild-type challenge. Interestingly, the avirogy and Biological Sciences Research Council (formerly A.F.R.C.). ulent ED71 was able to elicit a protective immune response, while replication was short-lived and correlated REFERENCES with a reduction in both clinical signs and pathology.
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